Lawrence C. Lapointe

North Ryde, NSW 2113, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.

Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.

Journal: Cancer medicine
Published: May 02, 2022

Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.

Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.

Journal: Cancer
Published: November 28, 2021

Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.

Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.

Journal: Clinical epigenetics
Published: November 04, 2020

Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC).

Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC).

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: June 03, 2020

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.

Journal: Cancer
Published: July 01, 2019

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer.

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer.

Journal: Genes
Published: August 10, 2016

Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests.

Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 09, 2016

A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.

A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.

Journal: Clinical and translational gastroenterology
Published: September 15, 2015

Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.

Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.

Journal: BMC cancer
Published: March 01, 2015

A two-gene blood test for methylated DNA sensitive for colorectal cancer.

A two-gene blood test for methylated DNA sensitive for colorectal cancer.

Journal: PloS one
Published: November 13, 2014

CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia.

CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia.

Journal: Epigenetics
Published: May 07, 2014

A panel of genes methylated with high frequency in colorectal cancer.

A panel of genes methylated with high frequency in colorectal cancer.

Journal: BMC cancer
Published: August 21, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026